Internal Market, Industry, Entrepreneurship and SMEs

Third stakeholder conference on biosimilar medicines

Third stakeholder conference on biosimilar medicines
Published on: 30/08/2017
More than 150 stakeholders share their clinical experiences with and best practices in biological medicines including biosimilars today in Brussels.
Event date: 05/05/2017
Location: Brussels - (Belgium)

Participants include representatives of patients, healthcare professionals, authorities and pharmaceutical companies. They’ll also discuss tendering under the new Public Procurement Directive. Its impacts on access to biosimilars are also part of the discussion. 

QuintilesIMS is presenting the update report on biosimilar competition in Europe.

A new 'information guide for healthcare professionals' will be launched at the event. The European Medicines Agency (EMA) prepared it together with the European Commission and scientific experts from the EU countries. The guide is an aid for EU healthcare professionals. It gives reference information on the science and regulation supporting the use of biosimilars.

The European Commission already published:

  • an information document for patients in 2016 (see documents below)
  • a consensus information paper in 2013 (see documents below)

Together these documents form a comprehensive set of reliable information on biosimilars.

More information

See our 'projects' under the 'platform on access to medicines' on our biosimilars in the EU page.



Unit D3 - Biotechnology and Food Supply Chain: